Article Text

AB0080 In Both SLE and Seropositive RA, the Interleukin-6 (IL-6) System is Active, and Shifted towards Trans-Signalling
  1. M. Skwarek,
  2. J. Fantana,
  3. B. Heschel,
  4. M. Aringer
  1. Medicine III, University Medical Center Tu Dresden, Dresden, Germany


Background IL-6 signals via a receptor consisting of gp130 (CD130) and either membrane-bound IL-6 receptor α (CD126) present on leukocytes and hepatocytes or soluble (sIL-6Rα) on all other cells, the latter process being called trans-signalling.

Objectives To investigate the IL-6/IL-6 receptor system in SLE and compare it to healthy individuals (HC) and RA patients.

Methods We compared lymphocytes of 33 SLE, 16 RF and ACPA positive (RA+) and 12 seronegative (RA-) RA patients, and 50 HC. PBMC were stained with PE-labelled or control antibodies for CD126 and CD130. For determining Stat3 phosphorylation, PBMC were stimulated with IL-6 (250 ng/ml) for 10 min and 15 min, fixed with formaldehyde, permeabilized with methanol, and stained with PE-labelled anti-pStat3 or control antibodies. For in vitro experiments, HC PBMC were incubated for 24 hours in complete RPMI with or without the addition of IL-6, IL-10, TNF, interferon-α (IFNα) or combinations of these cytokines. CD126 staining was performed as above. Cells were analyzed on a Becton Dickinson FACSCalibur fluorocytometer, gating for lymphocytes. Increase in pStat3 mean fluorescence intensity (mfi) was used as an estimate of IL-6 signalling. Serum levels of IL-6 and soluble IL-6 receptor (sIL-6R) were measured by ELISA.

Results As compared to IL-6 serum levels of HC (0.5 (0.5-12.8) median (range) pg/ml), serum IL-6 was increased in SLE (3.7 (0.97-69.3) pg/ml, p<0.0001), RA+ (7.9 (2.4-158.5) pg/ml, p<0.0001) and RA- (5.1 (1.2-17.5) pg/ml, p<0.0001); RA+ IL-6 levels were significantly higher than those of SLE patients (p=0.02). The percentage of CD130+ lymphocytes, as compared to HC (61 (17-76) %), was significantly decreased in SLE (48% (15-85), p=0.003), but not RA+ (55 (41-73) %, p=0.1) or RA- patients (60 (49-77), p=0.7). The percentage of CD126+ lymphocytes, again compared to HC (61±9 (mean ± SD) %), was decreased in SLE (47±16%, p<0.0001) and RA+ (54±9%, p=0.007), but not RA- (61±13%, p=0.9) patients. Percentages of CD126+ and CD130+ lymphocytes were highly correlated with each other (r=0.82, (p<0.0001) for SLE; r=0.76 (p=0.0006) for RA+; r=0.9 (p<0.0001) for RA-). In contrast to the membrane receptor, sIL-6R serum levels (38.7 (18.1-66.9) ng/ml in HC) were increased in SLE (42.3 (26.9-109.6) ng/ml, p=0.03), RA+ (55.4±18.2 ng/ml, p=0.004), but also RA- (50.2±14 ng/ml, p=0.006). The decrease in surface receptor was functional in that IL-6, which induced a pStat3 mfi increase of 16.11±7.6 in HC lymphocytes, led to a significantly lesser increase in pSTAT3 in RA+ lymphocytes of 7.01±12.7 (p=0.02), and a trend (p=0.07) towards a diminished increase in SLE lymphocytes of 11.3±12.17. In vitro experiments showed that combinations of IL-6 with either TNF or interferon-α led to a pronounced reduction in the percentage of lymphocytes carrying CD126.

Conclusions IL-6 is increased in SLE, albeit less than in RA+. Cytokine combinations released in response to immune complexes induced a decrease in IL-6 receptors in vitro, which was similar to the in vivo situation. The concomitant increase in sIL-6R in SLE and RA+ sera points to receptor shedding. Reduction in surface receptors appeared to reduce IL-6 induced Stat3 phosphorylation. Thus, shedding may decrease leukocyte (and possibly hepatocyte) effects of IL-6, while increasing effects on other cells that rely on trans-signalling.

Disclosure of Interest M. Skwarek: None declared, J. Fantana: None declared, B. Heschel: None declared, M. Aringer Consultant for: Roche, Speakers bureau: Roche

DOI 10.1136/annrheumdis-2014-eular.4445

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.